Literature DB >> 10767626

Variability in nucleotide excision repair and cancer risk: a review.

S Benhamou1, A Sarasin.   

Abstract

Cancer initiation is classically associated with the induction of mutations on specific oncogenes or tumor suppressor genes, due to the presence of unrepaired DNA lesions produced by endogenous or exogenous genotoxic agents. Among several DNA repair pathways, the nucleotide excision repair (NER) is the most important and versatile one in removing the bulky adducts induced by physical and chemical carcinogens. Xeroderma pigmentosum (XP), characterized by a deficiency in NER and an over 1000-fold increased risk of skin cancer, represents a paradigm to understand the role of unrepaired lesion in the development of cancer. We reviewed here several NER assays used in epidemiological studies investigating the association between DNA repair efficiency and cancer risk. Reduced DNA repair could contribute to the development of cutaneous basal cell carcinoma (BCC), although discordant results have been reported. More consistent findings were observed between cellular sensitivity towards genotoxic agents and smoking-related cancers.

Entities:  

Mesh:

Year:  2000        PMID: 10767626     DOI: 10.1016/s1383-5742(00)00032-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  26 in total

1.  p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage.

Authors:  Carlos P Rubbi; Jo Milner
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

2.  Relating repair susceptibility of carcinogen-damaged DNA with structural distortion and thermodynamic stability.

Authors:  Min Wu; Shixiang Yan; Dinshaw J Patel; Nicholas E Geacintov; Suse Broyde
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

3.  DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.

Authors:  Sinan Trabulus; Gulgun S Guven; Mehmet R Altiparmak; Bahadir Batar; Ozlem Tun; Ayse S Yalin; Aydin Tunckale; Mehmet Guven
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

4.  Structure of DNA polymerase beta with a benzo[c]phenanthrene diol epoxide-adducted template exhibits mutagenic features.

Authors:  Vinod K Batra; David D Shock; Rajendra Prasad; William A Beard; Esther W Hou; Lars C Pedersen; Jane M Sayer; Haruhiko Yagi; Subodh Kumar; Donald M Jerina; Samuel H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-01       Impact factor: 11.205

5.  Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.

Authors:  Leelakumari Sreeja; Volga S Syamala; Vani Syamala; Sreedharan Hariharan; Praveenkumar B Raveendran; R V Vijayalekshmi; Jayaprakash Madhavan; Ravindran Ankathil
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-19       Impact factor: 4.553

6.  Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk.

Authors:  Robert R McWilliams; William R Bamlet; Julie M Cunningham; Ellen L Goode; Mariza de Andrade; Lisa A Boardman; Gloria M Petersen
Journal:  Cancer Res       Date:  2008-06-10       Impact factor: 12.701

7.  Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L.

Authors:  Robert R McWilliams; William R Bamlet; Mariza de Andrade; David N Rider; Julie M Cunningham; Gloria M Petersen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

8.  Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.

Authors:  Qiwei Yang; Archana Laknaur; Lelyand Elam; Nahed Ismail; Larisa Gavrilova-Jordan; John Lue; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2016-03-31       Impact factor: 3.060

9.  Selective pressures for and against genetic instability in cancer: a time-dependent problem.

Authors:  Natalia L Komarova; Alexander V Sadovsky; Frederic Y M Wan
Journal:  J R Soc Interface       Date:  2008-01-06       Impact factor: 4.118

10.  Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype.

Authors:  Yi-Wei Yao; Yi-Fu He; Xing-Hua Han; Chu-Shu Ji; Bing Hu
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.